BNP Paribas Financial Markets’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

BNP Paribas Financial Markets’s Portfolio BIB Stock Details BIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-195	Closed	-$13.6K	–	4148
2020 Q3	$13.6K	Sell	195 -610	-76%	-$43.3K	﹤0.01%	3918
2020 Q2	$58.4K	Buy	+805	New	+$51.4K	﹤0.01%	2975
2020 Q1	–	Sell	-167	Closed	-$10.3K	–	4333
2019 Q4	$10.3K	Sell	167 -1,826	-92%	-$97.4K	﹤0.01%	4124
2019 Q3	$84.8K	Buy	1,993 +380	+24%	+$18K	﹤0.01%	3202
2019 Q2	$83.6K	Buy	+1,613	New	+$80.3K	﹤0.01%	3136

Other funds holding BIB

SFS

Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

CIC

Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return

UMC

United Maritime Capital New York $15.2M AUM 45.42% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return

BNP Paribas Financial Markets's BIB Position: Q4 2020 in Review

BNP Paribas Financial Markets sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q4 2020, closing a stake of 195 shares — an estimated $13.6K sold.

BNP Paribas Financial Markets first reported a position in BIB in Q2 2019 and held it in 5 quarters. The position peaked at $84.8K in Q3 2019. 34 funds tracked by Wall St. Rank hold BIB as of Q4 2020.

BNP Paribas Financial Markets reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q4 2020 after selling out during the quarter.
BNP Paribas Financial Markets sold 195 ProShares Ultra NASDAQ Biotechnology shares in Q4 2020, an estimated $13.6K.
BNP Paribas Financial Markets first reported a position in ProShares Ultra NASDAQ Biotechnology in Q2 2019 and held it in 5 quarters.
BNP Paribas Financial Markets's ProShares Ultra NASDAQ Biotechnology position peaked at $84.8K in Q3 2019.
34 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q4 2020.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2020, filed 10 Feb 2021.